Last $2.72 USD
Change Today +0.0054 / 0.20%
Volume 49.8K
AXGN On Other Exchanges
Symbol
Exchange
Berlin
As of 8:10 PM 11/21/14 All times are local (Market data is delayed by at least 15 minutes).

axogen inc (AXGN) Key Developments

AxoGen, Inc. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014

AxoGen, Inc. reported unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2014. For the quarter, the company reported revenues of $4,671,340 compared to revenue of $2,957,462 for the same period a year ago. Loss from operations was $1,802,904 compared to $2,276,994 last year. Net loss was $3,238,174 or $0.19 per basic and diluted share compared to $3,552,781 or $0.25 per basic and diluted share last year. For the nine months, the company reported revenues of $12,023,789 compared to revenue of $7,962,683 for the same period a year ago. Loss from operations was $7,091,791 compared to $6,794,877 last year. Net loss was $11,219,210 or $0.64 per basic and diluted share compared to $10,448,090 or $0.86 per basic and diluted share last year. Net cash used for operating activities was $8,019,485 compared to $8,061,343 last year. Purchase of property and equipment was $342,875 compared to $66,564 last year. Acquisition of intangible assets was $39,454 compared to $50,262 last year.

AxoGen, Inc. to Report Q3, 2014 Results on Nov 13, 2014

AxoGen, Inc. announced that they will report Q3, 2014 results After-Market on Nov 13, 2014

AxoGen, Inc., Q3 2014 Earnings Call, Nov 13, 2014

AxoGen, Inc., Q3 2014 Earnings Call, Nov 13, 2014

AxoGen, Inc. Presents at BioFlorida Annual Conference, Oct-14-2014 09:30 AM

AxoGen, Inc. Presents at BioFlorida Annual Conference, Oct-14-2014 09:30 AM. Venue: Harbor Beach Marriott, Ft. Lauderdale, Florida, United States. Speakers: John P. Engels, Co-Founder and Vice President.

John McLaughlin Resigns as Member of the Board of Directors of AxoGen, Inc

On August 20, 2014, John McLaughlin delivered the notice of his resignation as a member of the Board of Directors of AxoGen, Inc. effective as of the date of the notice. The Board accepted Mr. McLaughlin’s notice of resignation. Mr. McLaughlin had served as a member of the Board since October 2012.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AXGN:US $2.72 USD +0.0054

AXGN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Baxter International Inc $72.44 USD +0.45
Integra LifeSciences Holdings Corp $47.50 USD +0.01
Stryker Corp $90.11 USD +0.46
View Industry Companies
 

Industry Analysis

AXGN

Industry Average

Valuation AXGN Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 3.2x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AXOGEN INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.